中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2008年
8期
685-690
,共6页
徐瑞霞%CHEN Xi%胡盛寿%陈静海%刘学文%LIU Xue-bin%石林惠%CONG Xiang-feng
徐瑞霞%CHEN Xi%鬍盛壽%陳靜海%劉學文%LIU Xue-bin%石林惠%CONG Xiang-feng
서서하%CHEN Xi%호성수%진정해%류학문%LIU Xue-bin%석림혜%CONG Xiang-feng
骨髓祖代细胞%洛伐他汀%细胞凋亡
骨髓祖代細胞%洛伐他汀%細胞凋亡
골수조대세포%락벌타정%세포조망
Myeloid progenitor cells%Lovastatin%Apoptosis
目的 体外以缺氧无血清条件模拟心肌梗死后的心脏缺血微环境,研究洛伐他汀能否抑制缺氧无血清引起的骨髓间充质干细胞(MSC)凋亡并探讨其机制.方法 以Hocchst33342染色荧光显微镜观察法及Annexin V/PI流式细胞术检测洛伐他汀的抗凋亡作用,并进一步采用Westernblot方法 检测洛伐他汀对线粒体凋亡途径的抑制作用以及对磷脂酰肌醇3激酶(PI3K)/丝氨酸苏氨酸激酶(Akt)途径和丝裂原活化的蛋白激酶(MAPK)的激酶(MEK)/细胞内信号调节蛋白激酶(ERK1/2)途径的激活作用.结果 0.01~1 μmol/L浓度范围的洛伐他汀能够有效地抑制缺氧无血清引起的MSC凋亡.洛伐他汀抑制线粒体凋亡途径,洛伐他汀抑制细胞色素C释放,降低天冬氨酸特异性半胱氨酸蛋白酶-3(caspase-3)活化,从而保护线粒体功能.洛伐他汀的抗凋亡效应以及其抑制细胞色素C释放的作用均可被PI3K抑制剂LY294002和MEK抑制剂U0126阻断.洛伐他汀能够激活PI3K/Akt和MEK/ERK1/2两条细胞存活信号通路,分别导致Akt和GSK-3β及ERK1/2磷酸化.结论 洛伐他汀能够抑制线粒体凋亡途径,并激活PI3K/Akt和MEK/ERK1/2细胞存活通路,最终发挥抗缺氧无血清引起的MSC凋亡.该研究为提高移植干细胞的存活率提供了一种可能有效的干预措施.
目的 體外以缺氧無血清條件模擬心肌梗死後的心髒缺血微環境,研究洛伐他汀能否抑製缺氧無血清引起的骨髓間充質榦細胞(MSC)凋亡併探討其機製.方法 以Hocchst33342染色熒光顯微鏡觀察法及Annexin V/PI流式細胞術檢測洛伐他汀的抗凋亡作用,併進一步採用Westernblot方法 檢測洛伐他汀對線粒體凋亡途徑的抑製作用以及對燐脂酰肌醇3激酶(PI3K)/絲氨痠囌氨痠激酶(Akt)途徑和絲裂原活化的蛋白激酶(MAPK)的激酶(MEK)/細胞內信號調節蛋白激酶(ERK1/2)途徑的激活作用.結果 0.01~1 μmol/L濃度範圍的洛伐他汀能夠有效地抑製缺氧無血清引起的MSC凋亡.洛伐他汀抑製線粒體凋亡途徑,洛伐他汀抑製細胞色素C釋放,降低天鼕氨痠特異性半胱氨痠蛋白酶-3(caspase-3)活化,從而保護線粒體功能.洛伐他汀的抗凋亡效應以及其抑製細胞色素C釋放的作用均可被PI3K抑製劑LY294002和MEK抑製劑U0126阻斷.洛伐他汀能夠激活PI3K/Akt和MEK/ERK1/2兩條細胞存活信號通路,分彆導緻Akt和GSK-3β及ERK1/2燐痠化.結論 洛伐他汀能夠抑製線粒體凋亡途徑,併激活PI3K/Akt和MEK/ERK1/2細胞存活通路,最終髮揮抗缺氧無血清引起的MSC凋亡.該研究為提高移植榦細胞的存活率提供瞭一種可能有效的榦預措施.
목적 체외이결양무혈청조건모의심기경사후적심장결혈미배경,연구락벌타정능부억제결양무혈청인기적골수간충질간세포(MSC)조망병탐토기궤제.방법 이Hocchst33342염색형광현미경관찰법급Annexin V/PI류식세포술검측락벌타정적항조망작용,병진일보채용Westernblot방법 검측락벌타정대선립체조망도경적억제작용이급대린지선기순3격매(PI3K)/사안산소안산격매(Akt)도경화사렬원활화적단백격매(MAPK)적격매(MEK)/세포내신호조절단백격매(ERK1/2)도경적격활작용.결과 0.01~1 μmol/L농도범위적락벌타정능구유효지억제결양무혈청인기적MSC조망.락벌타정억제선립체조망도경,락벌타정억제세포색소C석방,강저천동안산특이성반광안산단백매-3(caspase-3)활화,종이보호선립체공능.락벌타정적항조망효응이급기억제세포색소C석방적작용균가피PI3K억제제LY294002화MEK억제제U0126조단.락벌타정능구격활PI3K/Akt화MEK/ERK1/2량조세포존활신호통로,분별도치Akt화GSK-3β급ERK1/2린산화.결론 락벌타정능구억제선립체조망도경,병격활PI3K/Akt화MEK/ERK1/2세포존활통로,최종발휘항결양무혈청인기적MSC조망.해연구위제고이식간세포적존활솔제공료일충가능유효적간예조시.
Objective To investigated the effect of lovastatin on hypoxia and serum deprivation (Hypoxia/SD) induced rat MSCs apoptosis in vitro and associated signaling pathway changes. Methods MSCs were isolated from Sprague-Dawley rats. The anti-apoptotic effects of lovastatin were detected using Hoechst33342 and annexin V-FITC/PI binding assay by Flow cytometric analysis. The phosphorylation of Akt and ERK1/2, the cytochrome C and the cleaved caspase-3 were detected by Western blot. Results Lovastatin (0. 01 - 1 μmol/L)significantly reduced Hypoxia/SD-induced MSCs apoptosis and increased Akt phosphorylation, reduced caspase-3 activation and cytochrome c release from mitochondria to cytosol in a time dependent manner. These effects could be significantly blocked by both PI3K inhibitor, LY294002 and ERK1/2 inhibitor, U0126. Conclusions Our results showed that lovastatin protects MSCs from Hypoxia/ SD-induced apoptosis via activating PI3K/Akt and ERK1/2 signaling pathways suggesting a potential role of statins as an adjunct therapeutic agent during transplanting MSCs into damaged heart after myocardial infarction.